The global challenge for skin health

British Journal of Dermatology

Volumn 172, Issue 6, 2015, Pages 1469-1472

  Hay, R J ^a,b   Augustin, M ^a,c   Griffiths, C E M ^a,d   Sterry, W ^a,e  

^a International League of Dermatological Societies   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATITIS; FINANCIAL MANAGEMENT; HEALTH; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH IMPACT ASSESSMENT; HUMAN; IMMUNOSURVEILLANCE; MEDICAL RESEARCH; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN; SKIN DISEASE; CHRONIC DISEASE; COST OF ILLNESS; FORECASTING; HUMAN RELATION; LIFE EVENT; QUALITY OF LIFE; SKIN DISEASES; TRENDS;

BIOMEDICAL RESEARCH; CHRONIC DISEASE; COST OF ILLNESS; FORECASTING; GLOBAL HEALTH; HUMANS; INTERPERSONAL RELATIONS; LIFE CHANGE EVENTS; QUALITY OF LIFE; SKIN DISEASES;

EID: 84930331321     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13854     Document Type: Review

References (24)

1. Hay RJ, Johns NE, Williams HC, et al,. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014; 134: 1527-34.
2. Bickers DR, Lim HW, Margolis D, et al,. The burden of skin diseases: 2004. A joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006; 55: 490-500.
3. Picardi A, Lega I, Tarolla E,. Suicide risk in skin disorders. Clin Dermatol 2013; 31: 47-56.
4. Marmot M,. Social determinants of health inequalities. Lancet 2005; 365: 1099-104.
5. Meeting of the International Task Force for Disease Eradication-November 2012. Wkly Epidemiol Rec 2013; 88: 75-80.
6. Williams H, Stewart A, von Mutius E, et al,. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008; 121: 947-54.
7. Haar K, Romani L, Filimone R, et al,. Scabies community prevalence and mass drug administration in two Fijian villages. Int J Dermatol 2014; 53: 739-45.
8. Carapetis JR, Currie BJ, Kaplan EL,. Epidemiology and prevention of group A streptococcal infections: acute respiratory tract infections, skin infections, and their sequelae at the close of the 20th century. Clin Infect Dis 1999; 28: 205-10.
9. Takeichi T, Liu L, Fong K, et al,. Whole-exome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory. Br J Dermatol 2014; 172: 94-100.
10. United Nations Radio. UN Human Rights Council calls for protection of people with albinism. Available at: http://www.unmultimedia.org/radio/english/2013/06/un-human-rights-calls-for-protection-of-people-with-albinism/ (last accessed 20 April 2015).
11. Ghazizadeh R, Shimizu H, Tosa M, Ghazizadeh M,. Pathogenic mechanisms shared between psoriasis and cardiovascular disease. Int J Med Sci 2010; 7: 284-9.
12. Berger TG, Shive M, Harper GM,. Pruritus in the older patient: a clinical review. JAMA 2013; 310: 2443-50.
13. Staples M, Marks R, Giles G,. Trends in the incidence of non melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998; 78: 144-8.
14. Housman TS, Feldman SR, Williford PM, et al,. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003; 48: 425-9.
15. Fransen M, Karahalios A, Sharma N, et al,. Non-melanoma skin cancer in Australia. Med J Aust 2012; 197: 565-8.
16. Mahe A,. Epidemiology and management of common skin diseases in children in developing countries. Available at: http://whqlibdoc.who.int/hq/2005/WHO-FCH-CAH-05.12-eng.pdf (last accessed 20 April 2015).
17. Osterd K, Krekels GA, Nieman FH, et al,. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008; 9: 1149-56.
18. Sosman JA, Kim KB, Schuchter L, et al,. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 2012; 366: 707-14.
19. Tomczyk S, Tamiru A, Davey G,. Addressing the neglected tropical disease podoconiosis in Northern Ethiopia: lessons learned from a new community podoconiosis program. PLoS Negl Trop Dis 2012; 6: e1560.
20. Sartorelli P, Kezic S, Larese Filon F, John SM,. Prevention of occupational dermatitis. Int J Immunopathol Pharmacol 2011; 24 (Suppl. 1): 89S-93S.
21. Mallett DA, Kossicki G,. The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol 2008; 59: 772-80.
22. Hay RJ, Estrada Castanon R, Alarcon Hernandez H, et al,. Wastage of family income on skin disease-a study of skin infection in Guerrero, Mexico. BMJ 1994; 309: 848-9.
23. Sixty-Seventh World Health Assembly. Psoriasis. Available at: http://apps.who.int/gb/ebwha/pdf-files/WHA67/A67-R9-en.pdf (last accessed 20 April 2015).
24. World Health Organization. Scabies. Available at: http://www.who.int/neglected-diseases/diseases/scabies/en/ (last accessed 20 April 2015).